NDC 55289-920-98
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-920
- Requested NDC
- 55289-920-98
- Package NDCs from labels
- 55289-920-98
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-920-06 | EA - Each | 55289-920 | 706d0221-1af2-41d4-9df2-bf37b14b690f | 1 | 2012-07-24 |
| 55289-920-30 | EA - Each | 55289-920 | 29427292-7c0b-4173-859f-ff32c417f2e7 | 1 | 2012-07-24 |
| 55289-920-40 | EA - Each | 55289-920 | 27fb6d9e-1de6-4d20-a60e-6518e959ca62 | 1 | 2012-07-24 |
| 55289-920-60 | EA - Each | 55289-920 | d88ef8cb-70eb-456a-8133-6265354cbc4a | 1 | 2012-07-24 |
| 55289-920-90 | EA - Each | 55289-920 | cd4fb9c8-ca98-40b2-8d76-5faca8c9fb4e | 1 | 2012-07-24 |
| 55289-920-98 | EA - Each | 55289-920 | 2a336a9c-9f8d-4b3f-8c19-cc8e37318b9d | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nifedipine | NIFEDIPINE | PD-Rx Pharmaceuticals, Inc. | 89723620-474e-4b16-9f57-4e927efc401c | 2026-01-06 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Nifedipine | NIFEDIPINE | PD-Rx Pharmaceuticals, Inc. | 8e5e126a-7da6-4ceb-b72b-5c9dcc7d7769 | 2026-01-06 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | PD-Rx Pharmaceuticals, Inc. | 26cd56db-4727-40d1-8f08-3ee899052c77 | 2026-01-05 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | PD-Rx Pharmaceuticals, Inc. | 8a14ade6-d428-4144-9037-46955f68820f | 2026-01-05 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | d2a91b99-513d-4894-ad6d-02d2028a2290 | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | PD-Rx Pharmaceuticals, Inc. | 7767697f-4dd0-477d-b5cc-e1ed5689f097 | 2026-01-05 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Acetazolamide | ACETAZOLAMIDE | PD-Rx Pharmaceuticals, Inc. | c525ef20-ec9a-4ffd-b5ea-e53c186fe716 | 2026-01-05 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | PD-Rx Pharmaceuticals, Inc. | 643cdcff-8599-4326-b3ca-d9fd270e0fc2 | 2026-01-05 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Naproxen | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | fa2fe6fd-c476-dd29-e053-6294a90a9e9e | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Duloxetine | DULOXETINE | PD-Rx Pharmaceuticals, Inc. | db85a82d-84f1-41c8-964b-ac94ae4d8e7b | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Naproxen Sodium | NAPROXEN SODIUM | PD-Rx Pharmaceuticals, Inc. | 145cdcc0-9bd5-4a0e-81fc-11a24d181980 | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 9d529fe3-7b5c-4dde-9a8c-440a969df359 | 2026-01-05 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 90cc4f07-e0a3-4d50-a10a-8f6a7f9c5140 | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Alprazolam | ALPRAZOLAM | Northwind Health Company, LLC | 25174ee5-a86e-ab97-e063-6394a90acd87 | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | Alprazolam ALPRAZOLAM |
| Nabumetone | NABUMETONE | PD-Rx Pharmaceuticals, Inc. | 75c51686-9c5e-4c13-acf4-2d04502eedda | 2025-12-24 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 1496dfc1-de50-471c-be87-1f1e2b70ab5a | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Etodolac | ETODOLAC | PD-Rx Pharmaceuticals, Inc. | 80e9d756-9278-48bb-bfdd-7d070ae0f341 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| ibuprofen | IBUPROFEN | PD-Rx Pharmaceuticals, Inc. | 96bff700-bca3-4b94-b8a2-379102721db8 | 2025-12-15 | Warnings | PD-Rx Pharmaceuticals, Inc. |
| PROCHLORPERAZINE MALEATE | PROCHLORPERAZINE MALEATE | PD-Rx Pharmaceuticals, Inc. | 3b022837-0fcc-d38a-e063-6394a90a0f7f | 2025-12-15 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Alprazolam | ALPRAZOLAM | Aurobindo Pharma Limited | d2fd0b3e-9b78-44d0-82a6-96d6c6238750 | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | Alprazolam ALPRAZOLAM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.